David Glynn
Cost-effectiveness of 5 fraction and partial breast radiotherapy for early breast cancer in the UK: model-based multi-trial analysis.
Glynn, David; Bliss, Judith; Brunt, Adrian Murray; Coles, Charlotte E.; Wheatley, Duncan; Haviland, Joanne S.; Kirby, Anna M.; Longo, Francesco; Faria, Rita; Yarnold, John R.; Griffin, Susan
Authors
Judith Bliss
Professor Adrian Brunt m.brunt@keele.ac.uk
Charlotte E. Coles
Duncan Wheatley
Joanne S. Haviland
Anna M. Kirby
Francesco Longo
Rita Faria
John R. Yarnold
Susan Griffin
Abstract
PURPOSE: We estimated the cost-effectiveness of 4 radiotherapy modalities to treat early breast cancer in the UK. In a subgroup of patients eligible for all modalities, we compared whole-breast (WB) and partial breast (PB) radiotherapy delivered in either 15 (WB15F, PB15F) or 5 fractions (WB5F, PB5F). In a subgroup ineligible for PB radiotherapy, we compared WB15F to WB5F. METHODS: We developed a Markov cohort model to simulate lifetime healthcare costs and quality-adjusted life years (QALYs) for each modality. This was informed by the clinical analysis of two non-inferiority trials (FAST Forward and IMPORT LOW) and supplemented with external literature. The primary analysis assumed that radiotherapy modality influences health only through its impact on locoregional recurrence and radiotherapy-related adverse events. RESULTS: In the primary analysis, PB5F had the least cost and greatest expected QALYs. WB5F had the least cost and the greatest expected QALYs in those only eligible for WB radiotherapy. Applying a cost-effectiveness threshold of £15,000/QALY, there was a 62% chance that PB5F was the cost-effective alternative in the PB eligible group, and there was a 100% chance that WB5F was cost-effective in the subgroup ineligible for PB radiotherapy. CONCLUSIONS: Hypofractionation to 5 fractions and partial breast radiotherapy modalities offer potentially important benefits to the UK health system.
Journal Article Type | Article |
---|---|
Acceptance Date | Oct 18, 2022 |
Publication Date | Nov 17, 2022 |
Journal | Breast Cancer Research and Treatment |
Print ISSN | 0167-6806 |
Electronic ISSN | 1573-7217 |
Publisher | Springer Verlag |
Peer Reviewed | Peer Reviewed |
Volume | 197 |
Pages | 405-416 |
Publisher URL | https://link.springer.com/article/10.1007/s10549-022-06802-1 |
Files
Cost-effectiveness of 5 fraction and partial breast radiotherapy for early breast cancer in the UK model-based multi-trial a.pdf
(854 Kb)
PDF
Publisher Licence URL
https://creativecommons.org/licenses/by/4.0/
You might also like
Hypofractionation: The standard for external beam breast irradiation
(2023)
Journal Article
Hypofractionation: The standard for external beam breast irradiation
(2023)
Journal Article